Exelixis, Inc. - Common Stock (NQ:EXEL)
55.81
-1.29
(-2.25%)
Streaming Delayed Price
Updated: 11:08 AM EDT, Jul 10, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 488,774 |
| Open | 57.19 |
| Bid (Size) | 55.79 (200) |
| Ask (Size) | 55.84 (100) |
| Prev. Close | 57.10 |
| Today's Range | 55.66 - 57.27 |
| 52wk Range | 33.76 - 57.57 |
| Shares Outstanding | 315,048,788 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Exelixis Inc (NASDAQ:EXEL) Presents a Compelling Value Investment Case ↗
February 26, 2026
Prediction: This Stock Could Double By 2031 ↗
May 15, 2026
Exelixis (EXEL) Q1 2026 Earnings Transcript ↗
May 05, 2026
Exelixis: A Strong Contender in the Cancer Drug Market ↗
March 31, 2026
The Best Healthcare Stocks to Buy With $50 Right Now ↗
March 18, 2026
Frequently Asked Questions
Is Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 55.81
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 07/10/26 11:08 AM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 17.58B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.